1,238
Views
0
CrossRef citations to date
0
Altmetric
Articles

“We are looking at the future right now”: community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States

, , , , , , , , , , , , , , , , , , , & show all
Pages 120-135 | Received 09 Oct 2021, Accepted 12 Mar 2022, Published online: 29 Mar 2022

References

  • TAG. Research Toward a Cure Trials. 2021. Available: http://www.treatmentactiongroup.org/cure/trials
  • Julg B, Dee L, Ananworanich J, et al. Recommendations for Analytical Treatment Interruptions in HIV Research Trials. Report of a Consensus Meeting. Lancet HIV. 2019;6(4):e259–e268.
  • Dubé K, Evans D, Dee L, et al. We Need to Deploy Them Very Thoughtfully and Carefully”: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States. AIDS Res Hum Retroviruses 2018 Jan;34(1):67–79.
  • Julg B, Dee L, Ananworanich J, et al. Recommendations for Analytical Antiretroviral Treatment Interruptions in HIV Research Trials — Report of a Consensus Meeting. Lancet HIV 2019 Apr;6(4):e259–e268.
  • Li JZ, Smith DM, Mellors JW. The Need for Treatment Interruption Studies and Biomarker Identification in the Search for an HIV Cure. AIDS. 2015;29(12):1429–1432.
  • Giron L, Papasavvas E, Yin X, et al. Phospholipid Metabolism is Associated with Time to HIV Rebound upon Treatment Interruption. MBio 2021;12(1):e03444–20.
  • Giron L, Palmer C, Liu Q, et al. Non-Invasive Plasma Glycomic and Metabolic Biomarkers of Post-Treatment Control of HIV. Nat Commun. 2021;12(1):3922.
  • Abdel-Mohsen M, Richman D, Siliciano R, BEAT-HIV Delaney Collaboratory to Cure HIV-1 infection, et al. Recommendations for Measuring HIV Reservoir Size in Cure-Directed Clinical Trials. Nat Med. 2020;26(9):1339–1350.
  • Tasso. [cited 28 Aug 2021]. Available: https://www.tassoinc.com/
  • Peluso MJ, Dee L, Campbell D, et al. A Collaborative, Multidisciplinary Approach to HIV Transmission Risk Mitigation during Analytic Treatment Interruption. J Virus Erad. 2020;6(1):34–37.
  • Lelièvre J-D, Hocqueloux L. Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate. J Infect Dis. 2019;16:4–5.
  • Ugarte A, Romero Y, Tricas A, Casado C, Garcia F, Leal L. Unintended HIV-1 Infection during Analytical Treatment Interruption. J Infect Dis. 2020 Apr 27;221(10):1740–1742.
  • Dubé K, Kanazawa JT, Dee L, et al. Ethical and Practical Considerations for Mitigating Risks to Sexual Partners during Analytical Treatment Interruptions in HIV Cure-Related Reserch. HIV Res Clin Pr 2021;24:1–17.
  • Hall EW, Luisi N, Zlotorzynska M, et al. Willingness to Use Home Collection Methods to Provide Specimens for SARS-CoV-2/COVID-19 Research: Survey Study. J Med Internet Res. 2020;22(9):e19471–13.
  • Figueroa C, Johnson C, Ford N, et al. Reliability of HIV Rapid Diagnostic Tests for Self-Testing Compared with Testing by Health-Care Workers: A Systematic Review and Meta-Analysis. Lancet HIV. 2018;5(6):e277–e90.
  • Ballard AM, Haardöerfer R, Prood N, Mbagwu C, Cooper HLF, Young AM. Willingness to Participate in At-Home HIV Testing Among Young Adults Who Use Opioids in Rural Appalachia. AIDS Behav. 2021;25(3):699–708.
  • Merchant RC, Clark MA, Liu T, et al. Comparison of Home-Based Oral Fluid Rapid HIV Self-Testing Versus Mail-in Blood Sample Collection or Medical/Community HIV Testing By Young Adult Black, Hispanic, and White MSM: Results from a Randomized Trial. AIDS Behav. 2018;22(1):337–346.
  • Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and Acceptability on HIV Self-Testing Among Key Populations: A Literature Review. AIDS Behav. 2015;19(11):1949–1965.
  • Carballo-Dieguez A, Frasca T, Dolezal C, Balan I. Will Gay and Bisexually Active Men at High Risk of Infection Use Over-the-Counter Rapid HIV Tests to Screen Sexual Partners? J Sex Res. 2012;49(4):379–387.
  • Colfax G, Lehman J, Bindman A, et al. What Happened to Home HIV Test Collection Kits? Intent to Use Kits, Actual use, and Barriers to Use among Persons at Risk for HIV Infection. AIDS Care. 2002;14(5):675–626.
  • Melendez J, Hamill M, Armington G, Gaydos C, Manabe Y. Home-Based Testing for Sexually Transmitted Infections: Leveraging Online Resources during the COVID-19 Pandemic. Sex Transm Dis. 2021;48(1):e8–e10.
  • Pearson WS, Kreisel K, Peterman TA, et al. Improving STD Service Delivery: Would American Patients and Providers Use Self-Tests for Gonorrhea and Chlamydia? Prev Med. 2018;115:26–30.
  • Fajardo-Bernal L, Aponte-Gonzalez J, Vigil P, et al. Home-Based Versus Clinic-Based Specimen Collection in the Management of Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections. Cochrane Database Syst Rev 2015 Sep 29;2015(9):CD011317.
  • Lunny C, Taylor D, Hoang L, et al. Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis. PLoS One. 2015;10(7):e0132776–23.
  • Tiro JA, Betts AC, Kimbel K, et al. Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result . J Womens Health (Larchmt). 2019;28(3):384–392.
  • Anderson C, Breithaupt L, Des Marais A, et al. Acceptability and Ease of Use of Mailed HPV Self-Collection among Infrequently Screened Women in North Carolina. Sex Transm Infect. 2018;94(2):131–137.
  • Sultana F, Mullins R, English DR, et al. Women’s Experience with Home-Based Self-Sampling for Human Papillomavirus Testing. BMC Cancer. 2015;15(1):1–10.
  • Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of Self-Collection Sampling for HPV-DNA Testing in Low-Resource Settings: A Mixed Methods Approach. BMC Public Health. 2014;14:596.
  • Kahn JA, Bernstein DI, Rosenthal SL, et al. Acceptability of Human Papillomavirus Self Testing in Female Adolescents. Sex Transm Infect. 2005;81(5):408–414.
  • Huppert JS, Hesse EA, Bernard MA, et al. Acceptability of Self-Testing for Trichomoniasis Increases with Experience. Sex Transm Infect. 2011;87(6):494–500.
  • Siegler AJ, Mayer KH, Liu AY, et al. Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support Program. Clin Infect Dis. 2019;68(3):501–504.
  • Armstrong-Hough M, Ggita J, Turimumahoro P, et al. Something so hard”: A Mixed-Methods Study of Home Sputum Collection for Tuberculosis Contact Investigation in Uganda. Int j Tuberc Lung Dis. 2018;22(10):1152–1159.
  • Sudharsanan N, Chen S, Garber M, Bärnighausen T, Geldsetzer P. The Effect of Home-Based Hypertension Screening on Blood Pressure Change over Time in South Africa. Health Aff (Millwood). 2020;39(1):124–132.
  • Fuller G, Njune Mouapi K, Joung S, et al. Feasibility of Patient-Centric Remote Dried Blood Sampling: The Prediction, Risk, and Evaluation of Major Adverse Cardiac Events (PRE-MACE) Study. Biodemography Soc Biol. 2019;65(4):313–322.
  • Clarke S, Foster J. A History of Blood Glucose Meters and Their Role in Self-Monitoring of Diabetes Mellitus. Br J Biomed Sci. 2012;69(2):83–93.
  • Dubé K, Auerbach JD, Stirratt MJ, Gaist P. Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research. J Int AIDS Soc. 2019;22(10):e25404.
  • FDA. Patient-Focused Drug Development: Methods to Identify What is Important to Patients. Silver Spring, Maryland, United States: Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. 2019.
  • Cresswell J. Research Design. Qualitative, Quantitative, and Mixed Methods Approaches. 4th ed. Thousand Oaks, CA, United States: Sage Publications; 2013.
  • AIDSVu. Local Data: Philadelphia. 2021 [cited 8 Oct 2021]. Available: https://aidsvu.org/local-data/united-states/northeast/pennsylvania/philadelphia/
  • Matovu JKB, Nambuusi A, Nakabirye S, Wanyenze RK, Serwadda D. Formative Research to Inform the Development of a Peer-Led HIV Self-Testing Intervention to Improve HIV Testing Uptake and Linkage to HIV Care among Adolescents, Young People and Adult Men in Kasensero Fishing Community, Rakai, Uganda: A Qualitative Study. BMC Public Health. 2020;20(1):1–16.
  • Ibitoye M, Lappen H, Freeman R, Jordan AE, Aronson ID. Technology-Based Interventions to Increase Point-of-Care HIV Testing and Linkage to Care Among Youth in the US: A Systematic Review. AIDS Behav. 2021;25(6):1829–1838.
  • Colfax G, Buchbinder S, Vamshidar G, et al. Motivations for Participating in an HIV Vaccine Efficacy Trial. JAIDS. 2005;39(3):359–364.
  • Eyal N. How to Address the Risk of HIV Transmission in Remission Studies With Treatment Interruption: The Low-Hanging Fruit Approach. J Infect Dis. 2019;220(220 Suppl 1):S7–S11.
  • Sakhi AK, Bastani NE, Ellingjord-Dale M, Gundersen TE, Blomhoff R, Ursin G. Feasibility of Self-Sampled Dried Blood Spot and Saliva Samples Sent by Mail in a Population-based Study. BMC Cancer. 2015;15(1):1–9.
  • Rockett JC, Buck GM, Lynch CD, Perreault SD. The Value of Home-Based Collection of Biospecimens in Reproductive Epidemiology. Environ Health Perspect. 2004;112(1):94–104.
  • Guest G, Bunce A, Johnson L. How Many Interviews Are Enough?: An Experiment with Data Saturation and Variability. Field Methods. 2006;18(1):59–82.